Trial Profile

Phase 1b trial evaluating safety and immune response of breast cancer vaccine

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 10 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Jun 2025 Status changed from recruiting to active, no longer recruiting.
03 Jun 2025 According to an Anixa Biosciences media release, the company has recently completed the enrollment in the study.
19 May 2025 According to an Anixa Biosciences media release, trial is nearing enrollment completion. Monitoring and data analysis will continue over the next three to four months, and we hope to present final results at the San Antonio Breast Cancer Symposium in early December 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com